Impact of coronary microvascular dysfunction in heart failure with preserved ejection fraction: a meta‐analysis

Domenico D'Amario,Renzo Laborante,Emiliano Bianchini,Giuseppe Ciliberti,Donato Antonio Paglianiti,Mattia Galli,Attilio Restivo,Davide Stolfo,Rocco Vergallo,Giuseppe M.C. Rosano,Filippo Crea,Carolyn S.P. Lam,Lars H. Lund,Marco Metra,Giuseppe Patti,Gianluigi Savarese
DOI: https://doi.org/10.1002/ehf2.14626
2024-03-30
ESC Heart Failure
Abstract:Aims Several mechanisms have been identified in the aetiopathogenesis of heart failure with preserved ejection fraction (HFpEF). Among these, coronary microvascular dysfunction (CMD) may play a key pathophysiological role. We performed a systematic review and meta‐analysis to investigate the prevalence, echocardiographic correlates, and prognostic implications of CMD in patients with HFpEF. Methods and results A systematic search for articles up to 1 May 2023 was performed. The primary aim was to assess the prevalence of CMD. Secondary aims were to compare key echocardiographic parameters (E/e′ ratio, left atrial volume index [LAVi], and left ventricular mass index [LVMi]), clinical outcomes [death and hospitalization for heart failure (HF)], and prevalence of atrial fibrillation (AF) between patients with and without CMD. Meta‐regressions according to baseline patient characteristics and study features were performed to explore potential heterogeneity sources. We identified 14 observational studies, enrolling 1138 patients with HFpEF. The overall prevalence of CMD was 58%. Compared with patients without CMD, patients with HFpEF and CMD had larger LAVi [mean difference (MD) 3.85 confidence interval (CI) 1.19–6.5, P
cardiac & cardiovascular systems
What problem does this paper attempt to address?